Lawsuits accuse Fresenius of concealing on GranuFlo, NaturaLyte risks

Fri, 01/18/2013 - 2:00pm
Mass Device

A spate of lawsuits across the country accuse Fresenius of deliberately concealing problems with its GranuFlo and Naturalyte products, alleging that the dialysis additives caused patients to die.

A spate of lawsuits accuse Fresenius Medical (NYSE:FMS) of deliberately concealing potentially fatal problems with a pair of since-recalled products used during dialysis.

The GranuFlo and Naturalyte products were used to lower the acidity of patients' blood during dialysis treatments. At least 15 lawsuits filed since Jan. 1 allege that the dialysates' high concentration of acetone led to abnormally high levels of bicarbonate in the blood, leading to fatal heart problems and strokes, according to court documents.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.